Variant NM_000492.4:c.2988+1G>A
| Name | NM_000492.4:c.2988+1G>A |
| Protein name | NP_000483.3:p.(=) |
| Genomic name (hg19) | chr7:g.117246808G>A UCSC |
| Genomic name (hg38) | chr7:g.117606754G>A UCSC |
| #Exon/intron | intron 18 |
| Legacy Name | 3120+1G>A |
| Class | disease-causing |
| Subclass | CF-causing |
| WT sequence | TCTTACCATATTTGACTTCATCCAG G TATGTAAAAATAAGTACCGTTAAGT |
| Mutant sequence | TCTTACCATATTTGACTTCATCCAG A TATGTAAAAATAAGTACCGTTAAGT |
![]() |
![]() | dbSNP rs75096551 |
![]() Not found | ![]() |
| Reference | PMID | Modulator | in vitro / ex vivo data | clinical data | Patient responsiveness |
| Burgel et al., 2024 | 39151434 | ELX-TEZ-IVA | N.D. | yes | no |
1 individuals carrying this variant are reported in CFTR-NGS catalogue |
| TOTAL NUMBER OF PATIENTS | 48 |
|---|---|
| CF | 36 |
| CFTR-RD | 7
|
| Pending | 1 |
| Pending (NBS) | 4 |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| Phenotype | Patient ID | Variant status | Additional variants |
|---|---|---|---|
| CF | 4557 | heterozygote | CF-causing - Trans |
| CF | 2624 | heterozygote | CF-causing- Undef |
| CF | 2604 | heterozygote | CF-causing - Trans |
| CF | 2563 | heterozygote | CF-causing - Trans |
| CF | 2552 | heterozygote | varying clinical consequence- Undef |
| CF | 2498 | heterozygote | CF-causing- Undef |
| CF | 2075 | heterozygote | VUS2- Undef |
| CF | 1958 | heterozygote | CF-causing- Undef |
| CF | 5711 | heterozygote | CFTR-RD-causing - Trans |
| CF | 3231 | heterozygote | varying clinical consequence- Undef |
| CF | 6494 | heterozygote | VUS3- Undef |
| CF | 6493 | heterozygote | VUS3- Undef |
| CF | 6499 | heterozygote | likely CFTR-RD- Undef |
| CF | 3886 | heterozygote | CF-causing- Undef |
| CF | 5328 | heterozygote | CF-causing- Undef |
| CF | 6224 | heterozygote | varying clinical consequence- Undef |
| CF | 5878 | heterozygote | CF-causing - Trans |
| CF | 6490 | heterozygote | CF-causing- Undef |
| CF | 5529 | heterozygote | CF-causing - Trans |
| CF | 330 | heterozygote | CF-causing - Trans |
| CF | 327 | heterozygote | CF-causing - Trans |
| CF | 177 | heterozygote | CF-causing- Undef |
| CF | 176 | heterozygote | CF-causing- Undef |
| CF | 103 | heterozygote | CF-causing - Trans |
| CF | 102 | heterozygote | CF-causing - Trans |
| CF | 6512 | heterozygote | CF-causing- Undef |
| CF | 1919 | heterozygote | VUS4 - Trans CF-causing - Trans |
| CF | 5299 | heterozygote | VUS3- Undef |
| CF | 5100 | heterozygote | CF-causing- Undef |
| CF | 1826 | heterozygote | CF-causing- Undef |
| CF | 1815 | heterozygote | |
| CF | 1772 | heterozygote | CF-causing- Undef |
| CF | 94 | heterozygote | CF-causing - Trans |
| CF | 790 | homozygote | c.2988+1G>A - p.(=) - Trans |
| CF | 2570 | homozygote | c.2988+1G>A - p.(=) - Trans |
| CF | 101 | homozygote | c.2988+1G>A - p.(=) - Trans |
| CBAVD | 2071 | heterozygote | CFTR-RD-causing - Trans |
| CBAVD | 2631 | heterozygote | VUS3- Undef varying clinical consequence- Undef |
| CBAVD | 1957 | heterozygote | CFTR-RD-causing- Undef |
| CBAVD | 656 | heterozygote | varying clinical consequence- Undef |
| Bronchiectasis | 6488 | heterozygote | VUS3- Undef |
| Bronchiectasis | 5034 | heterozygote | CFTR-RD-causing- Undef |
| Pending (NBS) | 4354 | heterozygote | varying clinical consequence - Trans |
| Pending (NBS) | 3919 | heterozygote | VUS3 - Trans |
| Pending (NBS) | 5609 | heterozygote | VUS3 - Trans |
| Pending (NBS) | 5372 | heterozygote | VUS3- Undef |
| Pancreatitis | 2553 | heterozygote | |
| Pending | 5008 | heterozygote | varying clinical consequence- Undef |
| Color code: non disease-causing < likely benign < VUS < likely pathogenic < disease-causing |
| CFTR variants are clustered into five groups (click here for more details about the classification of variants): |
|